BNET Industries

Market Cap:$249.5K
Last Fiscal Year Sales:$17.6K
  • Public
  • US
Dow Jones Description

Nanobac Pharmaceuticals, Incorporated and its subsidiaries (which may be referred to as "Nanobac", "the Company", "NNBP", "we", "us", or "our") is a research-based bio-lifescience company formed in 1994 as a Florida corporation. The current business described below commenced in June 2003 with the acquisition of NanobacLabs Pharmaceuticals, Inc. We are a life science company dedicated to the discovery and developments of products and services to improve people's health through the detection and treatment of Calcifying Nanoparticles ("CNPs"), otherwise known as "nanobacteria". The Company's research is directed toward establishing the pathogenic role of nanobacteria in soft tissue calcification, particularly in coronary artery heart disease, prostatitis and vascular disease. Nanobac's drug discovery and development is focused on new and existing compounds that effectively inhibit, destroy or neutralize CNPs. Nanobac manufactures and markets In Vitro Diagnostic (IVD) kits and reagents for detecting calcifying nanoparticles. IVD products (blood and tissue tests) include assays, proprietary antibodies and reagents for uniquely recognizing CNPs. Nanobac's BioAnalytical Services works with biopharmaceutical partners to develop and apply methods for avoiding, detecting, and inactivating or eliminating CNPs from raw materials. Calcification is a significant feature in most diseases that are leading causes of death, including heart disease. ...

Contact Information

2727 W Martin Luther King Blvd Ste 850

Tampa, Florida 33607

nanobac.com

8132581064X224

NAICS Code Medical Laboratories: 621511

News & Analysis

nanobac pharmaceuticals inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
E Olavi Kajander Chief

Board of Directors

Name (plus bio) Position
Alex H Edwards Member of the Board of Directors and Assists
Stephan Rechtschaffen Board of Directors

Dr. E. Olavi Kajander is Chief Research and Science Officer at Nanobac Pharmaceuticals in Tampa. He founded Nanobac OY, a Finnish research and development company located in Kuopio, Finland which is is now a subsidiary of Nanobac Pharmaceuticals. Dr. Kajander also founded Abcell Corporation, a medical diagnostics company. Dr. Kajander is a professor at the University of Kuopio. His position at the University of Kuopio has elevated over the time of his tenure from Ph.D. candidate, to doctorate, assistant professor, associate professor and now as docent. He has taught many courses at the university for more than 12 years and was the Research Director in the Department of Biochemistry. Dr. Kajander was a Scripps Clinic & Resident Foundation post-doctoral research fellow in La Jolla, California. He has authored or co-authored more than 70 scientific research papers and review articles, two letters and more than 50 scientific abstract publications as well as several invited editorials in scientific texts and journals. He also co-authored a Microbiology textbook chapter on Nanobacteria. He has been involved in the production of a number of videos and documentaries about his discovery of Nanobacteria. He pioneered families of U.S. patents effective in many countries and now assigned to Nanobac Pharmaceuticals.

Organization Position Status
Nanobac Life Sciences, Inc. Chief Research and Science Officer Current
Nanobac Pharmaceuticals, Inc. Chief Current
Abcell Founder Former

Alex Edwards is a member of the Board of Directors and assists the company in a consultative capacity. From May 2002 through present, Mr. Edwards has been a Managing Director of 360 Partners, as well as President & CEO of 360 Energy. From January 1997 to May 2002, he was an executive with SRI/Surgical Express. His roles ranged from Vice President/General Manager to President. From February 1993 through December 1997, he worked in Sales and Marketing with Dianon Systems, Inc. His positions included Sales and Sales Management roles as well as Field and Corporate Marketing. Mr. Edwards served as an Officer in the United States Navy with duty assignments ranging from Shipboard Divisional Leadership to Executive Assistant for the Naval Surface Group Commander in Norfolk, Virginia. Mr. Edwards is a 1987 graduate of the United States Naval Academy.

Organization Position Status
Nanobac Life Sciences, Inc. President & CEO Current
Nanobac Life Sciences, Inc. Board of Directors Current
Nanobac Pharmaceuticals, Inc. Member of the Board of Directors and Assists Current
Nano Chemical Systems Holdings, Inc. Chief Executive Officer Former
Sports.Com CEO Former
Energy Limited CEO Former
Sports.Com President Former
Energy Limited President Former
Nano Chemical Systems Holdings, Inc. Chief Financial Officer Former
SRI/Surgical Express, Inc. Executive Former
Dianon Systems, Inc. Former

Organization Position Status
Vitality Corporation Co-Author Current
Wellness Inc. Co-Author Current
Nanobac Life Sciences, Inc. Current
Nanobac Pharmaceuticals, Inc. Board of Directors Current
Omega Institute Co-Founder Former
Rhinebeck Health Center Developer Former
Rhinebeck Health Center Director Former
advertisement
Click Here
     NNBP $0.00 0.00 (0.00% )
Average Volume 823,215
Shares Outstanding 249.51M
Market Cap 224.6K
Year High 0.01
Year Low 0.0005
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement